Timo Itzel

1.5k total citations
29 papers, 603 citations indexed

About

Timo Itzel is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Timo Itzel has authored 29 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Timo Itzel's work include Gene expression and cancer classification (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Bioinformatics and Genomic Networks (6 papers). Timo Itzel is often cited by papers focused on Gene expression and cancer classification (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Bioinformatics and Genomic Networks (6 papers). Timo Itzel collaborates with scholars based in Germany, United States and Colombia. Timo Itzel's co-authors include Andreas Teufel, T Maass, Claus Hellerbrand, Rainer Spang, Johannes Betge, Tianzuo Zhan, Frederik Marmé, Wiebke Erhart, Felix Stickel and Detlef Schuppan and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Bioinformatics.

In The Last Decade

Timo Itzel

29 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timo Itzel Germany 13 235 232 123 114 110 29 603
Twishi Gulati Australia 9 188 0.8× 218 0.9× 78 0.6× 81 0.7× 89 0.8× 13 466
Anne T. Schneider Germany 12 266 1.1× 407 1.8× 81 0.7× 138 1.2× 246 2.2× 19 766
Beatrice Conti Italy 10 144 0.6× 215 0.9× 61 0.5× 77 0.7× 83 0.8× 14 431
Pei Kee Goh Australia 6 195 0.8× 285 1.2× 147 1.2× 84 0.7× 77 0.7× 8 564
Tomoyuki Nemoto Japan 9 178 0.8× 358 1.5× 84 0.7× 202 1.8× 54 0.5× 30 723
Stephen A. Hoang United States 11 215 0.9× 265 1.1× 104 0.8× 108 0.9× 69 0.6× 16 573
Chenzhi Hao China 14 212 0.9× 239 1.0× 101 0.8× 159 1.4× 52 0.5× 19 525
Guohe Song China 10 113 0.5× 216 0.9× 131 1.1× 36 0.3× 142 1.3× 19 471
John Stoops United States 11 161 0.7× 247 1.1× 48 0.4× 126 1.1× 48 0.4× 16 493
Makoto Naito Japan 7 227 1.0× 388 1.7× 65 0.5× 107 0.9× 150 1.4× 16 774

Countries citing papers authored by Timo Itzel

Since Specialization
Citations

This map shows the geographic impact of Timo Itzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Itzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Itzel more than expected).

Fields of papers citing papers by Timo Itzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Itzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Itzel. The network helps show where Timo Itzel may publish in the future.

Co-authorship network of co-authors of Timo Itzel

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Itzel. A scholar is included among the top collaborators of Timo Itzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Itzel. Timo Itzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niedermair, Tanja, et al.. (2024). Nuclei Detection and Segmentation of Histopathological Images Using a Feature Pyramidal Network Variant of a Mask R-CNN. Bioengineering. 11(10). 994–994. 2 indexed citations
2.
Teufel, Andreas, Timo Itzel, Anca Zimmermann, et al.. (2024). Evaluation of Google Search Trends for Liver Diseases in Europe. Journal of Gastrointestinal and Liver Diseases. 33(2). 234–244. 1 indexed citations
3.
Itzel, Timo, Thomas Falconer, Jimyung Park, et al.. (2023). Efficacy of Co-Medications in Patients with Alcoholic Liver Disease. Digestive Diseases. 41(5). 780–788. 3 indexed citations
4.
Li, Moying, Timo Itzel, Thomas Falconer, et al.. (2023). Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology. 58(12). 1505–1513. 1 indexed citations
5.
Itzel, Timo, et al.. (2022). Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers. Cancers. 14(17). 4322–4322. 2 indexed citations
6.
Itzel, Timo, et al.. (2022). Deep view on HCC gene signatures: and their comparison with othercancers. Zeitschrift für Gastroenterologie. 60(1). e41–e41. 1 indexed citations
7.
Itzel, Timo, et al.. (2021). Prognostic Cancer Gene Expression Signatures: Current Status and Challenges. Cells. 10(3). 648–648. 60 indexed citations
8.
Scheiter, Alexander, Katja Evert, Antonio Cigliano, et al.. (2021). RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues. Molecular Oncology. 16(5). 1091–1118. 12 indexed citations
9.
Buitrago‐Molina, Laura Elisa, Silke Marhenke, Diana Becker, et al.. (2021). p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model. Cellular and Molecular Gastroenterology and Hepatology. 11(5). 1387–1404. 5 indexed citations
10.
Dietrich, Peter, Valerie Fritz, Tatjana Seitz, et al.. (2020). Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer. Journal of Clinical Investigation. 130(5). 2509–2526. 34 indexed citations
11.
Gaitantzi, H, Chen Cai, Vanessa Rausch, et al.. (2020). BMP-9 modulates the hepatic responses to LPS. Zeitschrift für Gastroenterologie. 3 indexed citations
12.
Wandrer, Franziska, Silke Marhenke, Arndt Vogel, et al.. (2020). TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death and Disease. 11(3). 212–212. 111 indexed citations
13.
Itzel, Timo, et al.. (2020). Hepamine - A Liver Disease Microarray Database, Visualization Platform and Data-Mining Resource. Scientific Reports. 10(1). 4760–4760. 2 indexed citations
14.
Ye, Liangtao, Lydia Kriegl, Florian P. Reiter, et al.. (2020). Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma. Clinical and Translational Gastroenterology. 11(1). e00124–e00124. 5 indexed citations
15.
Reiter, Florian P., Gerald Denk, Andreas Ziesch, et al.. (2019). Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells. Cellular Oncology. 42(5). 705–715. 19 indexed citations
16.
Itzel, Timo, Rainer Spang, T Maass, et al.. (2019). Random gene sets in predicting survival of patients with hepatocellular carcinoma. Journal of Molecular Medicine. 97(6). 879–888. 14 indexed citations
17.
Teufel, Andreas, Timo Itzel, Wiebke Erhart, et al.. (2016). Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Gastroenterology. 151(3). 513–525.e0. 153 indexed citations
18.
Teufel, Andreas, Michael Gerken, Timo Itzel, et al.. (2015). Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer. BMC Cancer. 15(1). 419–419. 18 indexed citations
19.
Staib, Frank, M Krupp, T Maass, et al.. (2013). CellMinerHCC: a microarray‐based expression database for hepatocellular carcinoma cell lines. Liver International. 34(4). 621–631. 14 indexed citations
20.
Krupp, M, Timo Itzel, T Maass, et al.. (2012). CellLineNavigator: a workbench for cancer cell line analysis. Nucleic Acids Research. 41(D1). D942–D948. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026